Inventor
KRAMPS THOMAS
DE29 patents
⚠️ This page may combine multiple inventors who share the name “KRAMPS THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUREVAC AG
12 patentsUS11266735B2Mar 8, 2022
Combination vaccine
CUREVAC AG40 citations97
US11034729B2Jun 15, 2021
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG35 citations97
US10729761B2Aug 4, 2020
Vaccination in newborns and infants
CUREVAC AG30 citations97
US10596252B2Mar 24, 2020
Vaccination in newborns and infants
CUREVAC AG30 citations97
US10172935B2Jan 8, 2019
Vaccination in newborns and infants
CUREVAC AG33 citations97
US10150797B2Dec 11, 2018
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG39 citations97
US9688729B2Jun 27, 2017
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG66 citations97
US10682426B2Jun 16, 2020
Rabies vaccine
CUREVAC AG30 citations94
US10588959B2Mar 17, 2020
Combination vaccine
CUREVAC AG30 citations94
US11369694B2Jun 28, 2022
Rabies vaccine
CUREVAC AG11 citations85
US12337031B2Jun 24, 2025
Combination vaccine
CUREVAC AG0 citations62
US11672856B2Jun 13, 2023
Vaccination in newborns and infants
CUREVAC AG0 citations62
CureVac SE
11 patentsUS11739125B2Aug 29, 2023
Respiratory syncytial virus (RSV) vaccine
CureVac SE10 citations94
US11965000B2Apr 23, 2024
Respiratory syncytial virus (RSV) vaccine
CureVac SE7 citations85
US11690910B2Jul 4, 2023
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
CureVac SE6 citations74
US12390520B2Aug 19, 2025
Vaccination in newborns and infants
CureVac SE0 citations62
US12240873B2Mar 4, 2025
Respiratory syncytial virus (RSV) vaccine
CureVac SE0 citations62
US12139513B2Nov 12, 2024
Respiratory syncytial virus (RSV) vaccine
CureVac SE0 citations62
US12083190B2Sep 10, 2024
Rabies vaccine
CureVac SE0 citations62
US12036277B2Jul 16, 2024
Vaccination with mRNA-coded antigens
CureVac SE0 citations62
US11975064B2May 7, 2024
Vaccination with mRNA-coded antigens
CureVac SE0 citations62
US12569549B2Mar 10, 2026
Flavivirus vaccine
CureVac SE0 citations57
US11931406B2Mar 19, 2024
Flavivirus vaccine
CureVac SE0 citations57
UNIV ZUERICH
2 patentsUS7252951B2Aug 7, 2007
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
UNIV ZUERICH0 citations48
US7049290B2May 23, 2006
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
UNIV ZUERICH0 citations48